SIS
CTIC

Sound Income Strategies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Sound Income Strategies’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed – – 1014
2022
Q2 		$0 Hold
20
– – ﹤0.01% 982
2022
Q1 		$0 Hold
20
– – ﹤0.01% 973
2021
Q4 		$0 Buy
+20
New +$49 ﹤0.01% 916
2021
Q3 		– Sell
-33
Closed – – 944
2021
Q2 		$0 Hold
33
– – ﹤0.01% 1095
2021
Q1 		$96 Hold
33
– – ﹤0.01% 938
2020
Q4 		$0 Hold
33
– – ﹤0.01% 983
2020
Q3 		$0 Hold
33
– – ﹤0.01% 975
2020
Q2 		$0 Hold
33
– – ﹤0.01% 922
2020
Q1 		$0 Hold
33
– – ﹤0.01% 926
2019
Q4 		$0 Hold
33
– – ﹤0.01% 818
2019
Q3 		$0 Hold
33
– – ﹤0.01% 806
2019
Q2 		$0 Hold
33
– – ﹤0.01% 811
2019
Q1 		$0 Hold
33
– – ﹤0.01% 854
2018
Q4 		$0 Hold
33
– – ﹤0.01% 866
2018
Q3 		$0 Hold
33
– – ﹤0.01% 925
2018
Q2 		$0 Hold
33
– – ﹤0.01% 846
2018
Q1 		$0 Hold
33
– – ﹤0.01% 704
2017
Q4 		$0 Buy
+33
New +$97 ﹤0.01% 607

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sound Income Strategies's CTIC Position: Q3 2022 in Review

Sound Income Strategies sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2022, closing a stake of 20 shares.

Sound Income Strategies first reported a position in CTIC in Q4 2017 and held it in 18 quarters. The position peaked at $96 in Q1 2021. 133 funds tracked by Wall St. Rank hold CTIC as of Q3 2022.

  • Sound Income Strategies reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2022 after selling out during the quarter.
  • Sound Income Strategies sold 20 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2022.
  • Sound Income Strategies first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2017 and held it in 18 quarters.
  • Sound Income Strategies's CTI BioPharma Corp. (DE) Common Stock position peaked at $96 in Q1 2021.
  • 133 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2022.

Based on Sound Income Strategies's 13F filing for Q3 2022, filed 18 Oct 2022.